Post-approval, observational studies can be used to address questions pertaining to safety surveillance, risk management, and efficacy. Correct study choice and effective execution are paramount to achieving the desired goals.

ICON’s Lifecycle Sciences group is dedicated to designing and implementing Phase IV and peri-approval solutions.

We are experienced in the design and implementation of these studies to collect real-world data with a focus on maximising the return on investment:

• Non-interventional, Observational Research
• Disease and Product Registries
• Post-Approval Safety-Surveillance Studies
• Phase IV Clinical Trials
• Epidemiologic Studies
• Patient-Reported Outcomes / Quality-of-Life Research
• Health Economic Evaluations
• Scientific and Medical Communications